Skip to main content

EagleClaw Capital Managment, LLC

Position in NVO — Novo Nordisk A S

CIK 1607636 BOSTON, MA

Position in NVO

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$3,051,381
+$692,031 QoQ
Shares Held
63,650
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#293
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

EagleClaw Capital Managment, LLC holds $45,392,435 across 12 Drug Manufacturers - General names. NVO ranks #6 (6.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 NVO
Novo Nordisk A S
This page
63,650 $3,051,381

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,051,381 63,650
2026-03-31 $2,359,350 64,200
2025-12-31 $3,289,392 64,650
2025-09-30 $3,559,683 64,150
2025-06-30 $4,496,653 65,150
2025-03-31 $4,524,016 65,150
2024-12-31 $5,664,417 65,850
2024-09-30 $7,840,759 65,850
2024-06-30 $9,031,873 63,275
2024-03-31 $8,188,710 63,775
2023-12-31 $6,724,250 65,000
2023-09-30 $5,865,630 64,500
2023-06-30 $5,194,743 32,100
2023-03-31 $5,148,179 32,350
2022-12-31 $4,632,011 34,225
2022-09-30 $3,424,781 34,375
2022-06-30 $3,830,406 34,375
2022-03-31 $3,817,343 34,375
2021-12-31 $3,956,400 35,325
2021-09-30 $3,403,554 35,450
2021-06-30 $3,162,317 37,750
2021-03-31 $2,479,370 36,775
2020-12-31 $2,476,182 35,450
2020-09-30 $2,718,184 39,150
2020-06-30 $2,511,158 38,350
2020-03-31 $2,483,250 41,250